Skip to main content
Hajj And Omrah
About SFDA
About SFDA
نظرة عامة
Authority Establishment
Authority Membership
Authority Activities
Authority Management
Board of directors
SFDA in vision 2030
Vision Realization Office
National Transformation Program
Health Sector Transformation Program
National Industrial Development and Logistics Program
Authority Strategy
Strategy
Authority Values
Annual Reports
Career and Life
Life in SFDA
Career General Goals
Information Lists
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Areas
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
نظرة عامة
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Evaluation Program
Decisions
نظرة عامة
Laws and Regulations
Guidelines
Drugs Circulars
forms
Circulars
FAQ
Sector Committee
نظرة عامة
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Studies and Research
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
نظرة عامة
Laws and Regulations
Guidelines
Forms
Circulars
FAQ
نظرة عامة
Scientific reports and statements
Laws and Regulations
Guidelines
Consumer Corner
Awareness Campaign
Topics of Interest
Interactive calculators
Media Centre
News
Rumours
Warnings
Events
Workshops
ميديا
Podcasts
Forms
Scientific Magazines And Articles
Eservices
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Font Resize
+A
A
-A
Contrast
عربي
Hajj And Omrah
About SFDA
About SFDA
نظرة عامة
Authority Establishment
Authority Membership
Authority Activities
Authority Management
Board of directors
SFDA in vision 2030
Vision Realization Office
National Transformation Program
Health Sector Transformation Program
National Industrial Development and Logistics Program
Authority Strategy
Strategy
Authority Values
Annual Reports
Career and Life
Life in SFDA
Career General Goals
Information Lists
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Areas
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
نظرة عامة
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Evaluation Program
Decisions
نظرة عامة
Laws and Regulations
Guidelines
Drugs Circulars
forms
Circulars
FAQ
Sector Committee
نظرة عامة
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Studies and Research
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
Laws and Regulations
Guidelines
forms
Circulars
FAQ
نظرة عامة
Laws and Regulations
Guidelines
Forms
Circulars
FAQ
نظرة عامة
Scientific reports and statements
Laws and Regulations
Guidelines
Consumer Corner
Awareness Campaign
Topics of Interest
Interactive calculators
Media Centre
News
Rumours
Warnings
Events
Workshops
ميديا
Podcasts
Forms
Scientific Magazines And Articles
Eservices
All
The Authority
Food
Drugs
Medical Devices
الأعلاف
Pesticides
Laboratories
Cosmetics
Tobacco
Halal
Nutrition
Home
Search Results
Containing any of the words
Only of the type
All
Conference
Eservices
Events
Periodic Safety
Sector Committee decisions
Vaccine Safety
Annual Report
Awareness Campaign
calculators
Cosmetics standards Project
Cosmetics Warning
covid pages
Drug evaluation reports
Drug Membership
Event
Forms
Hajj card
HAPC Committee Decisions
head of board
hpac-members
International Standard
List Drugs Withdrawal
List Registered Drugs
Marketed Products
Medical devices studies
Medical Report
Message
Open Data
Podcasts
portables service
Reference repositories drugs
Regulations exceptions
Rumours
Scientific Magazines and articles
Scientific reports and statement
sector committee
Speakers
Standard
Standards Projects For Medical Devices
Surveys
test
Warehouse
Awareness Article
Circulars
Clinical Trial
Drug Clinical Trial
Drug Log
Drug Safety Labeling
Excellent establishments list
Information List
Laboratories
Lists
List of hospital that reported sides effects
List Registered Pharmacies
List Shortage Drug
List Under registration Drugs / Under committee review
News
New SFDA Drug Approvals
Risk Minimization Activity
Risk Minimization Activity - New
Safety Alert
service providing facilities
Warnings
Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock
Awareness Article
Effect of Initial Combination Therapy With Sitagliptin, and Metformin on Glycemic Control in Patients With Type 2 Diabetes
Awareness Article
"“MERS-CoV Infection Treated with a Combination ofLopinavir/Ritonavir and Interferon Beta 1B: A Placebo-Controlled, Double-BlindRandomized Trial (MIRACLE Trial)”"
Drug Clinical Trial
"Prospective Observational Clinical Practice Study in the 1st LineManagement of mCRC with Erbitux ™ in combination with Chemotherapy"
Drug Clinical Trial
“MERS-CoV Infection Treated with a Combination of Lopinavir/Ritonavir and Interferon Beta 1B: A Placebo-Controlled, Double-Blind Randomized Trial (MIRACLE Trial)”
Drug Clinical Trial
Recent Study Indicates A Higher Risk of Heart Attack In Patients Infected With HIV-1 Taking Ziagen (Abacavir) and Videx (Didanosine)
Awareness Article
The Effect of Empagliflozin (SGLT2 Inhibitor) in Pulmonary Arterial Hypertension: A Single Arm Prospective Interventional Study
Drug Clinical Trial
An observational study to monitor 2- Combination regimen's patterns of oral hypoglycaemic agents in Type 2 diabetic patients in daily clinical practice in Saudi Arabia
Drug Clinical Trial
Single arm Phase I/II study of the safety, tolerability and efficacy of the investigational anti PD-L1 monoclonal antibody Durvalumab in combination with Paclitaxel in patients with metastatic triple negative PD-L1 positive breast cancer
Drug Clinical Trial
Safety Warning of accidental overdose reported in infants and children with intravenous paracetamol 10mg/mL solution for infusion (Perfalgan®)
Circulars
Pagination
First page
« First
Previous page
‹ Previous
…
الصفحة
15
الصفحة
16
الصفحة
17
الصفحة
18
Current page
19
الصفحة
20
الصفحة
21
الصفحة
22
الصفحة
23
…
Next page
Next ›
Last page
Last »